Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ALXN > SEC Filings for ALXN > Form 8-K on 8-Nov-2012All Recent SEC Filings

Show all filings for ALEXION PHARMACEUTICALS INC

Form 8-K for ALEXION PHARMACEUTICALS INC


8-Nov-2012

Other Events, Financial Statements and Exhibits


Item 8.01 Other Events.
On November 8, 2012, Alexion Pharmaceuticals, Inc. issued a press release announcing that its Board of Directors authorized the repurchase of up to $400 million of Alexion's common stock. A copy of the press release is attached as Exhibit 99.1 to this Form 8-K and incorporated herein by reference.



Item 9.01 Financial Statements and Exhibits.

(d)  Exhibits

99.1  Press Release issued by Alexion Pharmaceuticals, Inc. on November 8, 2012.



--------------------------------------------------------------------------------

                                   Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: November 8, 2012 ALEXION PHARMACEUTICALS, INC.

By: /s/ Michael V. Greco
Name: Michael V. Greco
Title: Associate General Counsel and Corporate Secretary

  Add ALXN to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ALXN - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.